Patients with ischemic heart disease and asymptomatic peripheral vascular disease determined by means of the ankle-arm index
Keywords:
ischemic heart disease, asymptomatic peripheral vascular disease, ankle-arm index, Angiology Service.Abstract
A serial cases descriptive study of 42 patients with ischemic cardiovascular disorders and asymptomatic peripheral vascular disease was carried out. They were admitted to the Cardiology Service of “Saturnino Lora Torres" Teaching Clinical Surgical Provincial Hospital in Santiago de Cuba from January to December, 2012, aimed at determining the frequency of this disease by means of the ankle-arm index estimation. In the series the low value of this index prevailed (64.0%), followed by the normal index (29.0%). It is necessary to highlight that only 7.0% presented arterial calcification over 1.3; data revealing the prevalence of the asymptomatic or subclinic peripheral vascular disease.
Downloads
References
2. Martín Álvarez A, Ortega Martín JM, Fernández Samos R, Fernández Morán MC, Vaquero Murillo F. Frecuentación por patología vascular en atención primaria. Angiología. 2005;57(3):237-42.
3. Hiatt WR, Hoag S, Hamman RF. Effect of diagnostic criteria on the prevalence of peripheral arterial disease. The San Luis Valley diabetes study. Circulation. 1995 [citado 10 Dic 2013];91(5):1472-9. Disponible en: http://circ.ahajournals.org/content/91/5/1472.full
4. Puras Mallagray E, Luján Huertas S, Gutiérrez Baz M, Cáncer Pérez S. Factores de riesgo y factores pronósticos en la arteriosclerosis precoz de extremidades inferiores. Angiología. 2002 [citado 10 Dic 2013];54(3):145-61.
5. Manzano L, García Díaz JD, Gómez Cerezo J, Mateos J, Del Valle FJ, Medina Asensio J, et al. Valor de la determinación del índice tobillo-brazo en pacientes de riesgo vascular sin enfermedad aterotrombótica conocida: estudio VITAMIN. Rev Esp Cardiol. 2006;59:662-70.
6. Mohler ER. Peripheral arterial disease identification and implications. Arch Intern Med. 2003 [citado 10 Dic 2013];163(19):2306-14. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/14581250
7. Criqui MH, Fronek A, Barrett Connor E, Klauber MR, Gabriel S, Goodman D. The prevalence of peripheral arterial disease in a defined population. Circulation. 1985 [citado 10 Dic 2013];71(3):510-5. Disponible en: https://circ.ahajournals.org/content/71/3/510.full.pdf#page=1&view=FitH
8. Mostaza JM, Lahoz C. Índice tobillo-brazo: una herramienta útil en la estratificación del riesgo cardiovascular. Rev Esp Cardiol. 2006 [citado 10 Dic 2013];59:647-9. Disponible en: http://www.revespcardiol.org/es/ndice-tobillo-brazo-una-herramienta-util/articulo/13091364/
9. Aránzazu Gómez M, López Rodríguez I, Machín Fernández J. Prevalencia de arteriopatía periférica no diagnosticada en población mayor de 64 años mediante determinación del índice tobillo-brazo. Cad Aten Primaria. 2005 [citado 15 Ene 2014];12(4):202-5. Disponible en: https://dialnet.unirioja.es/servlet/articulo?codigo=2327938
10. Alzamora MT, Baena Diez JM, Sorribes M, Forés R, Torean P, Vicheto M, et al. Peripheral arterial disease study (PERART): prevalence and predictive values of asymptomatic peripheral arterial occlusive disease related to cardiovascular morbidity and mortality. BMC Public Health. 2007 [citado 15 Ene 2014];7:348. Disponible en: http://bmcpublichealth.biomedcentral.com/articles/10.1186/1471-2458-7-348
11. Allison MA, Hiatt WR, Hirsch AT, Coll JR, Criqui MH. A high ankle-brachial index is associated with increased cardiovascular disease morbidity and lowered quality of life. J Am Coll Cardiol. 2008. [citado 10 Dic 2013]; 51:1292-8. Disponible en: http://content.onlinejacc.org/article.aspx?articleid=1187824
12. Pedregoza Palop F, Monreal Bosch M. Prevalencia de enfermedad arterial periférica en pacientes hipertensos en la población de Paterna mayores de 15 años mediante la determinación del índice tobillo-brazo. Trabajo de investigación. Barcelona: Universidad Autónoma de Barcelona; 2011.
13. Contreras Téllez EJ, Rodríguez Moctezuma JR, López Carmona JM, Munguía Miranda C, Aranda Moreno C, Peralta Pedrero ML. Enfermedad arterial periférica y factores de riesgo en pacientes diabéticos tipo 2. Diferencias en medio urbano y suburbano. Rev Med Inst Mex Seguro Soc. 2007 [citado 15 Ene 2014]; 45(2):117-22. Disponible en: http://www.imbiomed.com.mx/1/1/articulos.php?method=showDetail&id_articulo=69493&id_seccion=4110&id_ejemplar=6951&id_revista=250
14. Tendera M, Aboyans V, Bartelink ML, Baumgartner I, Clément D, Collet JP, et al. ESC Guidelines on the diagnosis and treatment of peripheral artery diseases. Eur Heart J. 2011 [citado 10 Dic 2013];32. Disponible en: http://eurheartj.oxfordjournals.org/content/ehj/32/22/2851.full.pdf
15. Mostaza JM, Manzano L, Suarez C, Fernández C, García de Enterría MM, Tirado R, et al. Different prognostic value of silent peripheral artery disease in type 2 diabetic and non-diabetic subjects with stable cardiovascular disease. Atherosclerosis. 2011;214(1):191-5.
16. Huelmos A, Jiménez J, Guijarro C, Belinchon JC, Puras E, Sánchez C, et al. Enfermedad arterial periférica desconocida en pacientes con síndrome coronario agudo: prevalencia y patrón diferencial de los factores de riesgo cardiovascular tradicionales y emergentes. Rev Esp Cardiol. 2005;58(12):1403-10.
17. Ness J, Aronow WS, Newkirk E, McDanel D. Prevalence of symptomatic peripheral arterial disease, modifiable risk factors, and appropriate use of drugs in the treatment of peripheral arterial disease in older persons seen in a University General Medicine Clinic. J Gerontol A Biol Sci Med Sci. 2005; 60(2):255-7.
18. Manzano L, Mostaza JM, Suárez C, Cairols R, Redondo R, Valdivielso P, et al. Modificación de la estratificación del riesgo vascular tras la determinación del índice tobillo-brazo en pacientes sin enfermedad arterial conocida. Estudio MERITO. Med Clin. 2007 [citado 15 Ene 2014];128(7). Disponible en: http://www.elsevier.es/es-revista-medicina-clinica-2-articulo-modificacion-estratificacion-del-riesgo-vascular-13099239
Published
How to Cite
Issue
Section
License
All the articles can be downloaded or read for free. The journal does not charge any amount of money to the authors for the reception, edition or the publication of the articles, making the whole process completely free. Medisan has no embargo period and it is published under the license of Creative Commons, International Non Commercial Recognition 4.0, which authorizes the copy, reproduction and the total or partial distribution of the articles in any format or platform, with the conditions of citing the source of information and not to be used for profitable purposes.